Ledger.Open graph →
SEC Form D · Amendment · filed April 13, 2017

Bioniz Therapeutics, Inc

Offering
$18.6M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Nazli Azimi · Irvine, CAExec · DirectorDavid E. Pyott · Irvine, CADirectorJoe Kiani · Irvine, CADirectorIlan Zipkin · Irvine, CADirectorDavid Hulshof · Leawood, KSDirectorDouglas C. Gordon · Highlands Ranch, CODirectorRichard C. Rizzuto · Highlands Ranch, CODirectorHenry M. Lomax · Charlotte, NCExec · DirectorBarry Funt · New York, NYExec · DirectorCharles P. Keates · Newtown Square, PADirectorMelissa T. Heim · Portland, ORDirectorMichael R. Markunas · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗